Phase III pivotal randomized study of Bio017 for epilepsy
Latest Information Update: 28 Apr 2021
At a glance
- Drugs BIO 017 (Primary)
- Indications Epilepsy
- Focus Registrational; Therapeutic Use
- Acronyms SATURN
- Sponsors Biom Therapeutics
- 28 Apr 2021 New trial record